| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.465 | 19.277 | 22.361 | 23.048 | 26.830 | 34.293 | 34.166 | 35.465 | 54.941 | 55.468 |
| Total Income - EUR | 15.465 | 19.304 | 22.362 | 23.048 | 26.846 | 34.293 | 34.195 | 35.466 | 54.961 | 55.491 |
| Total Expenses - EUR | 10.283 | 8.991 | 9.335 | 9.855 | 15.612 | 18.331 | 19.612 | 27.950 | 28.831 | 43.964 |
| Gross Profit/Loss - EUR | 5.182 | 10.313 | 13.026 | 13.193 | 11.234 | 15.962 | 14.584 | 7.515 | 26.130 | 11.527 |
| Net Profit/Loss - EUR | 4.718 | 9.734 | 12.537 | 12.585 | 10.966 | 15.623 | 14.242 | 7.161 | 25.581 | 10.640 |
| Employees | 1 | 1 | 1 | 0 | 3 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Neuropsihoterapy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 17.247 | 16.723 | 16.098 | 15.467 | 14.838 | 14.234 | 13.603 | 13.328 | 14.401 | 13.554 |
| Current Assets | 617 | 1.851 | 3.967 | 13.760 | 25.817 | 40.802 | 53.241 | 55.538 | 18.339 | 8.756 |
| Inventories | 0 | 162 | 0 | 2.105 | 2.365 | 2.638 | 2.519 | 2.562 | 2.783 | 2.135 |
| Receivables | 0 | 925 | 2.414 | 387 | 316 | 1.081 | 39.332 | 50.026 | 6.835 | 2.083 |
| Cash | 617 | 764 | 1.553 | 11.269 | 23.136 | 37.083 | 11.389 | 2.950 | 8.721 | 4.538 |
| Shareholders Funds | -8.419 | 1.401 | 13.914 | 26.243 | 36.701 | 51.628 | 64.724 | 66.002 | 25.629 | 17.836 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 26.282 | 17.173 | 6.151 | 2.984 | 3.955 | 3.409 | 2.120 | 2.864 | 7.110 | 4.474 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuropsihoterapy Srl